Similarly, a study by Buyuktepe et al., which has moderate GRADE scoring, used next generation sequencing assay in 95 GBM patients to investigate the most predictive CpG islands within MGMT promoter and its association with OS and PFS [25]. This evidence concerns the gene MGMT and glioblastoma.